89Zr-girentuximab PET/CT effect on management of patients with kidney masses
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
FDA grants Priority Review status for TLX250-CDx for kidney cancer PET/CT scans
The Food and Drug Administration (FDA) in America has accepted [...]
89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
New PET imaging agent for kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. Currently, diagnosis is [...]
Results from a phase 3 study of 89Zr-DFO-girentuximab for PET/CT imaging of kidney cancer
Researchers are looking for better ways to diagnose kidney cancer. [...]
IKCS 2019: Novel biomarkers for prognosis of kidney cancer
Two presentations at the International Kidney Cancer Symposium 2019 in [...]
